Donor Profiling and Cell Isolation for Scalable Cell and Gene Therapy Manufacturing

Discover how deeply characterized donor immune profiles and extensive HLA diversity can accelerate cell and gene therapy (CGT) development as well as how gentle, negative-selection isolation ensures those cells maintain their natural phenotype and maximum potency for a seamless transition into scalable manufacturing Key discussion points: Sourcing: How deeply phenotyped donor material can accelerate CGT development through better matching donor characteristics to specific research or manufacturing needs Profiling: How broad HLA diversity combined with health-linked metadata supports biologically informed experimental design for more accurate immunogenicity and alloreactivity studies Isolation: Preserve natural cell biology with negative selection, providing untouched cells of the donor’s true phenotype by avoiding receptor binding, ensuring cells remain in their native, high-potency state Manufacturing: High-viability cells with preserved memory phenotypes drive superior expansion and potency, enabling seamless scale-up and scale-out of your manufacturing workflow without the need for additional specialized equipment Additional resources on this and other topics: https://bioivt.com/resources/educatio... Questions, comments and requests: https://bioivt.com/about/contact-us Access BioIVT's products and services: https://bioivt.com Other previously aired webinars: https://bioivt.com/educational-conten...) Upcoming webinar notifications: https://bioivt.com/resources/newslett...